Mitral valve surgery for rheumatic heart disease

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Dominique Vervoort ◽  
Maral Ouzounian ◽  
Bobby Yanagawa
2020 ◽  
Vol 30 (9) ◽  
pp. 1281-1287
Author(s):  
Fekede A. Debel ◽  
Belete Zekarias ◽  
Tomasa Centella ◽  
Atnafu M. Tekleab

AbstractBackground:Rheumatic heart disease is the most common cardiac diseases in developing countries including Ethiopia. The current study aimed to describe the immediate surgical outcome following valve surgery for rheumatic heart disease in Ethiopia.Methods:Data were collected through chart abstraction from two centres in Addis Ababa, Ethiopia: the Cardiac Center of Ethiopia and El Ouzier cardiac centre. Included were all patients who were operated for rheumatic valvular heart disease in the mentioned centres by local cardiac surgical team during the period from June 2017 to April 2020. Demographic and clinical characteristics of the study population at admission and within 30 days of the index cardiac surgery were collected. Statistical Package for Social Sciences version 20.0 for windows was used to analyse the data.Result:Of the 114 patients included in the study (median age 31 years with interquartile range of 23–40), 62 (54.4%) of them were female. Surgical procedures done were triple valve surgery 9 (7.9%) patients, mitral and tricuspid valves 26 (22.8%) patients, double-valve 16 (14.0%) patients, single-valve surgery 50.9% (11 aortic and 47 mitral valves) of patients, redo mitral valve surgery 3 (2.6%) patients, and left maze with mitral valve surgery 2 (1.8%) patients. Of the total, 103 (90.4%) of them had mitral valve surgery. Post-operatively, 5 (4.4%) patients died within 30 days following the index surgery.Conclusion:Immediate surgical outcome following valve surgery for rheumatic heart disease had excellent outcome in our setting. This evidence can be taken as a show of success in building local capacity to manage rheumatic heart disease surgically.


2019 ◽  
Vol 35 (10) ◽  
pp. S167-S168
Author(s):  
A. Mazine ◽  
S. Tamirat ◽  
F. Agwar ◽  
K. Dejene ◽  
M. Bedru ◽  
...  

CHEST Journal ◽  
2008 ◽  
Vol 134 (4) ◽  
pp. 145P ◽  
Author(s):  
Jerome R. Santos ◽  
Maria Paz Mateo ◽  
Aileen Guzman-Banzon ◽  
Fernando Ayuyao ◽  
Teresita de Guia

2020 ◽  
Vol 4 (sup1) ◽  
pp. 138-139
Author(s):  
Amine Mazine ◽  
Shibikom Tamirat ◽  
Louis-Mathieu Stevens ◽  
Fekede Agwar ◽  
Kefelegn Dejene ◽  
...  

Heart Asia ◽  
2017 ◽  
Vol 9 (2) ◽  
pp. e010916 ◽  
Author(s):  
E Anne Russell ◽  
Warren F Walsh ◽  
Christopher M Reid ◽  
Lavinia Tran ◽  
Alex Brown ◽  
...  

2020 ◽  
Vol 21 (Supplement_1) ◽  
Author(s):  
R Horita ◽  
K Mahara ◽  
Y Izumi ◽  
M Terada ◽  
K Kishiki ◽  
...  

Abstract Background Tricuspid regurgitation (TR) sometimes deteriorate late after left-sided valve surgery. The recent guidelines recommend tricuspid valve repair at the same time as the left-sided valve surgery. However, little is known about the pathophysiology that leads to severe TR after left-sided valve surgery. Purpose To clarify the risk factors of the patients with severe TR after left-sided valve surgery. Methods We retrospectively investigated consecutive 526 patients diagnosed as severe TR from January 2004 to December 2018 at our hospital. Clinical background, echocardiographic parameters were evaluated. Demographic information and clinical data (including age, electrocardiograms, type of left-sided valve surgery, underlying valve diseases and history of pacemaker or ICD implantation) were obtained by chart review. Results Of the 526 patients with severe TR, 107 patients were after a left-sided valve surgery. Patients developed severe TR at a mean of 14.8 ± 8 years after surgery.The surgical indications were as follows: mitral valve stenosis (74 patients, 69%), mitral valve regurgitation (43 patients, 40%), aortic valve stenosis (37 patients, 35%) and aortic regurgitation (28 patients, 26%), respectively. The mean age at diagnosis of severe TR was 74 ± 10 years and 75 were female (70%). Among those patients, 32 patients (30%) had a tricuspid annuloplasty (TAP) with the first left-sided valve surgery. Ninety-five patients (88%) had atrial fibrillation (AF), 75 patients (70%) were diagnosed as rheumatic heart disease, 64 patients (60%) had pulmonary artery hypertension (PH) and 28 patients (26%) had a permanent pacemaker or ICD implantation. There were only 12 patients who had severe TR without AF. Eight of 12 patients without AF had PH, and permanent pacemakers were implanted in remaining 4 patients. Conclusions Almost all patients with severe TR after left-sided valve surgery present with AF and prevalence of rheumatic heart disease were about 70 percent. These two factors may be one of the important risk factors for severe TR after left-sided valve surgery.


Sign in / Sign up

Export Citation Format

Share Document